logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kedar Kirtane

H. Lee Moffitt Cancer Center and Research Institute
H指数:16
被引数:1,468

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trial

MDM2抑制剂Alrizomadlin（APG-115）在TP53野生型唾液腺癌中的I期临床试验

Nature Communications
IF15.7
2026-03-190
OAAI
Alexander T. Pearson; Jameel Muzaffar; Kedar Kirtane; Emily Bellile; Krithika Suresh; Ari J. Rosenberg; Francis Worden; Christine H. Chung; Everett Vokes; J. Chad Brenner; Apurva Bhangale; Jon McHugh; Kristy Warner; Felipe Nor; Jacques E. Nor; Keri Innes; Yifan Zhai; Tommy Fu; Paul L. Swiecicki
Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory Hurdles

推进实体瘤细胞疗法：克服生物学、操作和监管障碍的途径

Transplantation and Cellular Therapy
IF4.4
2026-02-260
PRE
Kedar Kirtane; Michael Kalos; Rocky Billups; Aude G. Chapuis; Vicki Coutinho; Steven A. Feldman; Brian Gastman; John Haanen; Patrick J. Hanley; Priti Hegde; Emily L. Hopewell; Bruce L. Levine; Frederick L. Locke; Marcela V. Maus; Nancy V. Nair; Michael Nathenson; Miguel-Angel Perales; Isabelle Rivière; Devanjan Sikder; Craig Tendler
Defining the tumor-infiltrating lymphocyte antigenic landscape in head and neck cancer
JOURNAL OF IMMUNOLOGY
IF3.4
2025-11-010
PRE
Hall, MacLean; Carter, Michael; Nagle, Luz; Branthoover, Holly; Ali, Johannes; Blauvelt, Jamie; Thomas, Ashley; Couchara, Nicholas; Brennan, Emily; Hall, Amy M.; Obertopp, Nina; Rodriguez-Valentin, Madeline; Rangel, Camila Lopez; Thomas, Mary; Biernacki, Maria; Taha, Alaa; Beatty, Matthew S.; Mullinax, John E.; Teer, Jamie; Jaeger, Alex; Kirtane, Kedar; Chung, Christine H.; Pilon-Thomas, Shari
Validation of the Functional Assessment of Cancer Therapy - Immune Checkpoint Modulator 17-Item Symptom Index (FACT-ICM-17) to facilitate implementation in research and clinical care

功能性癌症治疗评估-免疫检查点调节剂17项症状指数（FACT-ICM-17）的验证，以促进其在研究和临床护理中的应用

CANCER
IF5.1
2025-10-150
OA
Gudenkauf, Lisa M.; Tometich, Danielle B.; Hoogland, Aasha I.; Li, Xiaoyin; Kirtane, Kedar; Small, Brent J.; Barata, Anna; Gonzalez, Brian D.; Jacobs, K. D.; Chung, Christine H.; Shafique, Michael R.; Gray, Jhanelle; Khushalani, Nikhil I.; Postow, Michael A.; Cella, David; Webster, Kimberly A.; Dicker, Adam P.; Jim, Heather S. L.
Design of a cluster randomized multi-level intervention to decrease barriers to minority cancer patient referral and enrollment to cancer clinical trials: The ACT WONDER2S study

设计一项集群随机多水平干预，以减少少数民族癌症患者转诊和入组癌症临床试验的障碍：ACT WONDER2S研究

CONTEMPORARY CLINICAL TRIALS
IF1.9
2025-09-011
OAAI
Rollison, Dana E.; Garcia, Melany A.; Amorrortu, Rossybelle P.; Zhao, Yayi; Mittman, Brian; Turner, Kea; Kirtane, Kedar; Soliman, Hatem; Byrne, Margaret M.; Meade, Cathy; Gwede, Clement K.; Eschrich, Steven; Yin, Jun; Stanley, Nathanael B.; Fuzzell, Lindsay; Hernandez, Delilah; Vadaparampil, Susan T.
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis
CLINICAL CANCER RESEARCH
IF10.2
2024-08-211
PRE
Saba, Nabil F.; Chaudhary, Ritu; Kirtane, Kedar; Marra, Angelo; Ekpenyong, Asari; McCook-Veal, Ashley; Schmitt, Nicole C.; Gross, Jennifer H.; Patel, Mihir R.; Remick, Jill; Bates, James E.; Mcdonald, Mark W.; Rudra, Soumon F.; Stokes, William A.; Biernacki, Maria; Song, Xiaofei; Slebos, Robbert J. C.; Liu, Yuan; Steuer, Conor E.; Shin, Dong M.; Teng, Yong; Chung, Christine H.
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study

在1期KEYNOTE-603研究中，单独或与Pembrolizumab联合使用个体化新抗原治疗mRNA-4157 (V940) 的T细胞反应

CANCER DISCOVERY
IF33.3
2024-08-081
PRE
Gainor, Justin F.; Patel, Manish R.; Weber, Jeffrey S.; Gutierrez, Martin; Bauman, Julie E.; Clarke, Jeffrey M.; Julian, Ricklie; Scott, Aaron J.; Geiger, Jessica L.; Kirtane, Kedar; Robert-Tissot, Celine; Coder, Brandon; Tasneem, Moomal; Sun, Jing; Zheng, Wei; Gerbereux, Lauren; Laino, Andressa; Porichis, Filippos; Pollard, Jack Russella; Hou, Peijie; Sehgal, Vasudha; Chen, Xing; Morrissey, Manju; Daghestani, Hikmat N.; Feldman, Igor; Srinivasan, Lakshmi; Frederick, Joshua P.; Brown, Michelle; Aanur, Praveen; Meehan, Robert; Burris III, Howard A.
Molecular characterization of the salivary adenoid cystic carcinoma immune landscape by anatomic subsites

通过解剖亚位点对涎腺腺样囊性癌免疫景观进行分子表征

SCIENTIFIC REPORTS
IF3.9
2024-07-093
OAAI
Tasoulas, Jason; Schrank, Travis P.; Bharambe, Harish; Mehta, Jay; Johnson, Steven; Divaris, Kimon; Hackman, Trevor G.; Sheth, Siddharth; Kirtane, Kedar; Hernandez-Prera, Juan C.; Chung, Christine H.; Yarbrough, Wendell G.; Ferrarotto, Renata; Issaeva, Natalia; Theocharis, Stamatios; Amelio, Antonio L.
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial (vol 29, pg 880, 2023)
NATURE MEDICINE
IF50
2024-07-021
PRE
Saba, Nabil F.; Steuer, Conor E.; Ekpenyong, Asari; McCook-Veal, Ashley; Magliocca, Kelly; Patel, Mihir; Schmitt, Nicole C.; Stokes, William; Bates, James E.; Rudra, Soumon; Remick, Jill; Mcdonald, Mark; Abousaud, Marin; Tan, Aik Choon; Fadlullah, Muhammad Zaki Hidayatullah; Chaudhary, Ritu; Muzaffar, Jameel; Kirtane, Kedar; Liu, Yuan; Chen, Georgia Z.; Shin, Dong M.; Teng, Yong; Chung, Christine H.
Phase 2 study of oral CCR4 antagonist FLX475 (tivumecirnon) plus pembrolizumab in subjects with head and neck squamous cell carcinoma (HNSCC) previously treated with checkpoint inhibitor
CANCER RESEARCH
IF16.6
2024-04-051
PRE
Muzaffar, Jameel; Kirtane, Kedar; Redman, Rebecca; Yang, Muh-Hwa; Kim, Tae Min; Liu, Stephen; Lynch, Ryan; Brahmer, Julie; LoRusso, Patricia; Henick, Brian; Kim, Sung-Bae; Feng, Yin-Hsun; Chisamore, Michael; Kassner, Paul; Brockstedt, Dirk; Nasrah, Nicole; Goyal, Rakesh; Ho, William Y.; Villaflor, Victoria
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
NATURE MEDICINE
IF50
2023-04-0331
OA
Saba, Nabil F.; Steuer, Conor E.; Ekpenyong, Asari; McCook-Veal, Ashley; Magliocca, Kelly; Patel, Mihir; Schmitt, Nicole C.; Stokes, William; Bates, James E.; Rudra, Soumon; Remick, Jill; McDonald, Mark; Abousaud, Marin; Tan, Aik Choon; Fadlullah, Muhammad Zaki Hidayatullah; Chaudhary, Ritu; Muzaffar, Jameel; Kirtane, Kedar; Liu, Yuan; Chen, Georgia Z.; Shin, Dong M.; Teng, Yong; Chung, Christine H.
A2B530, AN AUTOLOGOUS CEA-DIRECTED TMOD TCELL THERAPY WITH AN INHIBITORY RECEPTOR GATED BY HLA-A*02 TO TARGET COLORECTAL, PANCREATIC, AND LUNG CANCER
JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2022-11-071
OA
Hecht, J. Randolph; Sandberg, Mark; Wang, Xueyin; Martin, Aaron; Nampe, Daniel; Gabrelow, Grant; Li, Chuck; Mcelvain, Michele; Lee, Wen-Hua; Shafaattalab, Sanam; Martire, Sara; Fisher, Fernando; Ando, Yuta; Liu, Edwin; Ju, David; Hsin, Jing-Ping; Zampieri, Alexandre; Simeone, Diane; Kopetz, Scott; Morelli, Maria Pia; Borad, Mitesh; Welling, Theodore; Patel, Sandip; Garon, Edward; Kirtane, Kedar; Locke, Frederick; Welch, John; Ng, Eric; Go, William; Mardiros, Armen; Maloney, David; Wong, Lu-Min; Kamb, Alexander; Xu, Han; Molina, Julian

研究方向

暂未获取到该数据
C
Christine H. Chung
H 指数:67论文数:650被引数:2.8万
H
Heather Jim
H 指数:55论文数:481被引数:1.2万
J
Jameel Muzaffar
H 指数:17论文数:124被引数:931
B
Brian D. Gonzalez
H 指数:33论文数:210被引数:3,836
A
Aasha I. Hoogland
H 指数:22论文数:152被引数:1,571
L
Laura B. Oswald
H 指数:21论文数:149被引数:1,787
N
Nabil F. Saba
H 指数:60论文数:860被引数:2.1万
J
Jill Remick
H 指数:13论文数:76被引数:1,172
J
Jimmy J. Caudell
H 指数:50论文数:333被引数:1.1万
J
John S. Welch
H 指数:46论文数:313被引数:2.3万